A comprehensive view of West Pharmaceutical Services Inc.. This page highlights a small sample of our full coverage.
For real-time access, please log in to your Health Care Sector Market Intelligence Service.
WEST PHARMACEUTICAL SERVICES INC - 10-Q - MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS
Published:
April 25, 2024
by SEC Edgar Filings
|
West Pharmaceutical reports Q1 net income of US$115.3M, revenue of US$695.4M; company forecasts full year revenue of between US$3.0B to US$3.03B
Published:
April 25, 2024
by Associated Press
|
West announces first-quarter 2024 results and declares third-quarter 2024 dividend
Published:
April 25, 2024
by PR Newswire
|
WEST PHARMACEUTICAL SERVICES INC - (8-K) - Disclosing Results of Operations and Financial Condition, Regulation FD Disclosure, Financial Statements and Exhibits
Published:
April 25, 2024
by SEC Edgar Filings
|
INTERNATIONAL PATENT: WEST PHARMACEUTICAL SERVICES, INC. FILES APPLICATION FOR "VIAL ADAPTER FOR CLOSURE SYSTEMS"
Published:
April 23, 2024
by U.S. Fed News
|
Ask us about our Health Care Sector market view